Novel cytotoxic Rhodium and Iridium Compounds and their use as anticancer drugs and antimetastatic agents
These novel rhodium complexes were tested on breast cancer (MCF-7) and colon cancer (HT-29) cell lines and exhibit cytotoxicities of up to 100 times higher than Cisplatin.
Further Information: PDF
rubitec – Gesellschaft für Innovation und Technologie der Ruhr-Universität Bochum mbH
Phone: +49 (0)234/32-11969
Contact
Dietmar Tappe
Media Contact
All latest news from the category: Technology Offerings
Newest articles
Molecular gardening: New enzymes discovered for protein modification pruning
How deubiquitinases USP53 and USP54 cleave long polyubiquitin chains and how the former is linked to liver disease in children. Deubiquitinases (DUBs) are enzymes used by cells to trim protein…
Machine learning accelerates catalyst discovery
Conceptual blueprint to analyze experimental catalyst data. Machine learning (ML) models have recently become popular in the field of heterogeneous catalyst design. The inherent complexity of the interactions between catalyst…
More efficient car designs with AI
8,000 open source models for sustainable mobility. Designing new cars is expensive and time consuming. As a result, manufacturers tend to make only minor changes from one model generation to…